首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Discordance in lymphoid tissue recovery following stem cell transplantation in rhesus macaques: an in vivo imaging study
【24h】

Discordance in lymphoid tissue recovery following stem cell transplantation in rhesus macaques: an in vivo imaging study

机译:恒河猴猕猴干细胞移植后淋巴组织恢复的不一致:一项体内成像研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Ionizing irradiation is used routinely to induce myeloablation and immunosuppression. However, it has not been possible to evaluate the extent of ablation without invasive biopsy. For lymphoid recovery, peripheral blood (PB) lymphocytes (PBLs) have been used for analysis, but they represent <2% of cells in lymphoid tissues (LTs). Using a combination of single-photon emission computed tomography imaging and a radiotracer (Tc-99m-labeled rhesus immunoglobulin G1 anti-CD4R1 (Fab')(2)), we sequentially imaged CD4(+) cell recovery in rhesus macaques following total body irradiation (TBI) and reinfusion of vector-transduced, autologous CD34(+) cells. Our results present for the first time a sequential, real-time, noninvasive method to evaluate CD4(+) cell recovery. Importantly, despite myeloablation of circulating leukocytes following TBI, total depletion of CD4(+) lymphocytes in LTs such as the spleen is not achieved. The impact of TBI on LTs and PBLs is discordant, in which as few as 32.4% of CD4(+) cells were depleted from the spleen. In addition, despite full lymphocyte recovery in the spleen and PB, lymph nodes have suboptimal recovery. This highlights concerns about residual disease, endogenous contributions to recovery, and residual LT damage following ionizing irradiation. Such methodologies also have direct application to immunosuppressive therapy and other immunosuppressive disorders, such as those associated with viral monitoring.
机译:电离辐射通常用于诱导骨髓消融和免疫抑制。但是,没有进行侵入性活检就无法评估消融程度。对于淋巴样恢复,外周血(PB)淋巴细胞(PBL)已用于分析,但它们代表淋巴组织(LTs)中细胞的<2%。结合使用单光子发射计算机断层扫描成像和放射性示踪剂(Tc-99m标记的恒河猴免疫球蛋白G1抗CD4R1(Fab')(2)),我们依次对恒河猴体内的CD4(+)细胞回收率进行了成像辐射(TBI)和载体转导的自体CD34(+)细胞的再输注。我们的结果首次提出了一种顺序,实时,非侵入性的方法来评估CD4(+)细胞的恢复。重要的是,尽管TBI后循环白细胞发生了骨髓消融,但仍未实现LTs(如脾脏)中CD4(+)淋巴细胞的全部消耗。 TBI对LTs和PBLs的影响是不一致的,其中只有32.4%的CD4(+)细胞从脾脏中耗竭。此外,尽管脾脏和PB中淋巴细胞已完全恢复,但淋巴结恢复欠佳。这突出了对残留疾病,内源性恢复贡献以及电离辐射后残留LT损伤的担忧。这些方法还直接应用于免疫抑制治疗和其他免疫抑制疾病,例如与病毒监测有关的疾病。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号